Stem Cell Transplantation in Crohn's Disease
Public ClinicalTrials.gov record NCT04224558. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Autologous Hematopoietic Stem Cell Transplantation for Refractory Crohn's Disease
Study identification
- NCT ID
- NCT04224558
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Cedars-Sinai Medical Center
- Other
- Enrollment
- 15 participants
Conditions and interventions
Conditions
Interventions
- Acetaminophen Drug
- Apheresis catheter placement Procedure
- Cyclophosphamide Drug
- Cytoxan Drug
- Diphenhydramine Drug
- Filgrastim Drug
- Fludarabine Drug
- Leukapheresis Procedure
- Mesna Drug
- Methylprednisolone Drug
- Peripheral Blood Stem Cell Infusion Biological
- anti-thymocyte globulin (rabbit) Drug
- lymphocyte immune globulin Drug
Drug · Procedure · Biological
Eligibility (public fields only)
- Age range
- 13 Years to 28 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 14, 2019
- Primary completion
- Sep 29, 2027
- Completion
- Sep 29, 2027
- Last update posted
- Feb 19, 2026
2019 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04224558, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 19, 2026 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04224558 live on ClinicalTrials.gov.